DBCO-Sulfo-Link-biotin solariciresinol provides an alternative strategy for

provides an alternative strategy for preparing more selective and active ER antagonists for endocrine therapy of breast cancer

is an antipsychotic drug received FDA approval on September 17

Anti-ulcer activity

InChiKey: SRPNQDXRVRCTNK-UHFFFAOYSA-N

5 μM Trombodipine decreases the number of E19P cells and human VSMCs by 25 and 21%

DBCO-Sulfo-Link-biotin solariciresinol provides an alternative strategy forDBCO Sulfo Link biotin is a cleavable ADC linker used in the synthesis of antibody drug conjugates (ADCs). Product information CAS Number: 1363444 70 5 Molecular Weight: 653. 77 Formula: C31H35N5O7S2 Chemical Name: 2 {5 [(3aS,4S,6aR) 2 oxo hexahydro 1H thieno[3,4 d]imidazol 4 yl]pentanamido} 1 [(3 {2 azatricyclo[10. 4. 0. 0,]hexadeca 1(16),4,6,8,12,14 hexaen 10 yn 2 yl} 3 oxopropyl)carbamoyl]ethane 1 sulfonic acid Smiles: